The Government’s Unprecedented Equity Portfolio Has a Distressingly Weak Legal Foundation
As my colleague Tad DeHaven announced here earlier this week, Cato just launched the Restoring Free Enterprise project to analyze the federal government’s growing and unprecedented ownership of private US companies and to propose ways to reverse this troubling trend. The United States’ new portfolio — now encompassing 35 different companies across a range of industries — raises numerous problems that the RFE project will document, and my latest Dispatch column covers what may be the most basic one: the complete lack of explicit legal authority to do any of these equity deals.
As shown in the following table, the Trump administration has cited several laws to justify the government’s new shareholding arrangements, yet none of them expressly authorize the executive branch to take an ownership stake in a private US company.

These laws explicitly authorize grants, loans, and other government subsidies and contain vague language (e.g., “other transactions”) that the Trump administration has interpreted as justifying government shareholding. However, I explain in my column:
- No US president prior to Trump has taken such an expansive view of these laws or used them to acquire shares of a private US company.
- Congress has expressly authorized government equity stakes when it wanted the executive branch to be able to take them (see, e.g., the Troubled Asset Relief Program and the CARES Act). It rejected equity authority in the CHIPS Act, and it has not yet approved recent Republican proposals to authorize the Pentagon to make equity investments.
- Trump administration officials have publicly admitted that the executive branch lacks equity authority in several instances, and they have asked Congress to provide such power (which, again, it hasn’t yet done).
- The Trump administration has failed to offer a solid public justification for any of these deals on any legal grounds, and leaked internal memos are alarmingly weak sauce. This March, the Pentagon promised Congress an official memo outlining the legal basis for its equity deals, but we’re still waiting for it.
As I explain in my Dispatch column, the administration’s approach here raises a host of legal and practical problems and could, ironically, make unwinding these deals more difficult. It also sets the stage for the president — Trump or his successor — to do more equity deals and assert even more state control over private businesses and the US economy.
A forthcoming RFE essay by Cato legal expert Molly Nixon will dig into these and other legal questions in greater detail. In the meantime, be sure to check all the other new RFE content we’ve just put online.
Source: https://www.cato.org/blog/governments-unprecedented-equity-portfolio-has-distressingly-weak-legal-foundation
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

